A large number of loci for genetic diseases have been mapped on the human genome and a group of hereditary diseases among them have thus far proven unsuccessful to clone. It is conceivable that such "unclonable" diseases are not linked to abnormalities of protein coding genes (PCGs), but of non-coding RNAs (ncRNAs). We developed a novel approach termed OMiR (OMIM and miRNAs), to test whether microRNAs (miRNAs) exhibit any associations with mapped genetic diseases not yet associated with a PCG. We found that "orphan" genetic disease loci were proximal to miRNA loci more frequently than to loci for which the responsible protein coding gene is known, thus suggesting that miRNAs might be the elusive culprits. Our findings indicate that inclusion of miRNAs among the candidate genes to be considered could assist geneticists in their hunt for disease genes, particularly in the case of rare diseases.
Introduction
The Online Mendelian Inheritance in Man database (OMIM, http:// www.ncbi.nlm.nih.gov/sites/entrez?db=OMIM) contains information, including responsible PCGs, phenotypes, linkage data and references, on all human inherited or heritable disorders. Considered a phenotypic companion to the human genome project, and as of August 2010, OMIM comprised 4613 Mendelian diseases (which are prefixed using '#' (n= 2837) if the responsible gene is known and with '%' otherwise (n = 1776)), 367 genes with an associated phenotype (prefixed using '+'), and 13173 genes (including 183 microRNAs) with known sequence (prefixed using '*').
MicroRNAs (miRNAs) are small RNA molecu'les typically between 19 and 22 nucleotides in length that act as negative regulators of gene expression and are produced from larger primary transcripts (primiRNAs) [1] . In animal cells, miRNAs bind the RNA-induced silencing complex (RISC) and specific target messenger RNAs (mRNAs), which either remain untranslated or are degraded [2] . Many investigators have reported that miRNAs are critical in stem cell function [3] and tissue development [4] , are involved in viral infections [5] and are associated with oncogenesis [6] [7] [8] [9] . Furthermore, we previously reported that miRNAs are frequently located at human Cancer Associated Genomic Regions (CAGRs), such as amplified or deleted regions [10] or mouse modifier loci [11] . Mattick and colleagues recently reported that orthologous miRNA genes are located in CAGRs in human and mouse [12] . However, with the exception of X-linked mental retardation [13] , miRNAs have not been thought of as possible causal of Mendelian diseases. To test the hypothesis that some miRNAs could be potentially responsible for a number of "orphan" Mendelian diseases, we developed the OMiR method and used it to conduct a bioinformatics study.
Methods

OMIM Morbid Map
The Morbid Map is an alphabetical list of diseases described in OMIM with their corresponding cytogenetic locations and related mapping studies and references (http://www.ncbi.nlm.nih.gov/ Omim/getmorbid.cgi). We used Morbid Map to extract OMIM identifications (IDs) and corresponding disease names and loci. Information for diseases labeled using the OMIM IDs and prefixes was converted from cytogenetic location to base position using the UCSC Table Browser (available at http://genome.ucsc.edu/cgi-bin/hgTables, March 2006 release). We focused on: a) entries with a confirmed Mendelian phenotype or phenotypic locus for which the underlying molecular basis is not known (the diseases are prefixed with '%') and b) descriptive entries, usually of a phenotype with known molecular basis that does not represent a unique locus (prefixed with '#'). For statistical purposes, we considered as unknowns the OMIM diseases with a '%' prefix and as controls the '#' prefixed OMIM diseases because the genes responsible for them are known (and are not miRNAs). We examined also the OMIM diseases with prefix '*' (a gene of known sequence) and '+' (a known gene and corresponding phenotype) as controls. If an OMIM ID was associated to more than one locus, each locus was tested separately.
Extraction and management of miRNA information
The names, chromosome location, start and end positions of 939 miRNAs were downloaded from miRBase release 15.0 (ftp://mirbase. org/pub/mirbase/CURRENT/genomes/hsa.gff). Because each miRNA maps to a much smaller region (about 100 nt) than that mapped to the disease (millions of bp), if two or more miRNAs are significantly associated with an OMIM locus, then they are considered (a posteriori) as a relevant cluster.
Identifying significant associations of microRNAs and PCGs with OMIM disease loci
For a given OMIM locus, we computed its overlap (i.e. the number of common nucleotides between the miRNAs and the OMIM locus) with the loci of known miRNA transcripts. The probability (p-value) of the observed overlap was computed given the empirical null distribution of overlaps, which was estimated using 10,000 randomly reshuffled versions of the miRNA loci on each chromosome of the genome: each reshuffled set of loci yielded an overlap value, and all these overlaps comprise the empirical null distribution of overlaps. Finally, the false discovery rate (FDR) was calculated by comparing the distribution of p-values against the empirical null distribution of expected p-values, which was estimated using the same 10,000 randomly reshuffled miRNA loci. As before, each reshuffled version yields an overlap value, whose p-value can be computed using the entire set of 10,000 overlap values. All these p-values comprise the empirical null distribution of p-values. This method has been applied to miRNAs and PCGs' transcript loci independently in order to compare the relative number of statistically significant associations obtained. Human ENSEMBL release 54 was used to obtain the PCG loci and miRBase 15.0 to obtain miRNAs loci.
MiRNA target analysis
A miRNA target analysis was performed to determine if the identified associations could reveal whether the functions of mRNA targets could be related to the associated disease. Using the David Bioinformatics Resources system (http://david.abcc.ncifcrf.gov), we compared the list of terms related to the predicted targeted mRNAs. The terms were evaluated by Bonferroni p-value correction (Pb 0.05). We evaluated Gene Ontology (biological process, molecular function and cellular component, http://www.geneontology.org/), INTERPRO (http://www. ebi.ac.uk/interpro/), PATHWAY (http://www.biocarta.com/ and http:// www.genome.jp/kegg/), UP_TISSUE (http://david.abcc.ncifcrf.gov/) and SP_PIR_KEYWORDS (functional category) and OMIM disease (http://www.ncbi.nlm.nih.gov/omim/). The predicted targeted mRNAs were retrieved using miRGen (http://www.diana.pcbi.upenn.edu/data/ Fig. 1 . The five steps of OMiR algorithm: 1) OMIM ID information extraction and conversion; 2) Overlap between miRNAs or Protein Coding Genes loci and OMIM loci; 3) 10,000 randomly reshuffled overlaps, 4) P-value and Q value calculation; and 5) Extraction of the significant overlaps. Fig. 2 . Ratios between the percentage of significant OMIM::miRNAs associations and OMIM::mRNAs associations, for each OMIM ID type studied: '%', molecular basis unknown, '#' molecular basis known and '*' and '+', known sequence and/or phenotype. public/PublicData/miRGen/v3/Targets/) and RNA22 (http://cbcsrv. watson.ibm.com/rna22.html) with the following parameters: minimum number of paired-up bases in heteroduplex=12, maximum folding energy for heteroduplex=−25 kcal/mol, maximum number of allowed UN-paired bases=0 in seed/nucleus of 6 nucleotides.
Results
OMiR was implemented in perl and C++. First, we converted the OMIM, miRNAs and PCGs information from cytogenetic regions in base positions corresponding to various locations of OMIM diseases and genes. Then, we calculated the associations between miRNAs or clusters of miRNAs or mRNAs and OMIM diseases loci and finally validated these through permutations. The five steps of OMiR are presented in the Fig. 1 . Out of the total number of associations, at 1% FDR (false discovery rate) we found 5.06%, 8.46% and 10.15% significant associations (P b 0.05) between miRNAs and OMIM IDs '*' or '+', between miRNAs and the '#' prefixed OMIM diseases and miRNAs and the OMIM diseases with a '%' prefix, respectively. The percentages of associations with mRNAs, in the same OMIM IDs categories were 48.25% ('*' or '+'), 52.45% ('#') and 38.55% ('%') respectively. Based on the generalized hypothesis of 10,000 available associations, the Fisher exact test between the categories '#' and '%' was P b 0.001, while using all three categories was P b 0.001 (Fig. 2) . Table 1 reports the significant associations between 10 "orphan" diseases and 6 miRNAs clusters containing 63 miRNAs in total (6.7% of the human miRNAs from miRBase 15.0), (Supplemental file MiRNAs_OMIM_Asso-ciations.xls reports all found 88 significant associations).
Then we explored for 6 of the 88 significant '%' associated miRNAs the mRNAs target terms using DAVID (http://david.abcc.ncifcrf.gov/) (Table S1 ; the complete lists of significant target terms are reported in Supplemental Materials (Table S2 -S7 for RNA22 predicted targets and file miRGen_DAVID.zip for miRGen predicted targets)). In several instances, the related Gene Ontology, INTERPRO, PATHWAY, UP_TIS-SUE and SP_PIR_KEYWORDS functional terms were indeed relevant for the claimed associated disease. Table 1 shows the significant associations obtained for miRNAs associated with '%' by statistical validation using 10,000 permutations (P b 0.05, FDR b 1%). For example, the cluster miR-297, miR-302a, miR-302b, miR-302c, miR-302d, miR-367, miR-376 is significantly associated by OMiR to UAQTL1 (uric acid concentration serum, quantitative trait locus 1), gout (Table 2 ).
Discussion
Traditionally, Mendelian disorders have been classified as recessive or dominant and by OMIM based on type of known information about them. However, there is increasing recognition that these classifications can be explored to find possible candidate for "orphan" diseases. Here, we investigated the possible association of miRNAs with human "orphan" diseases. We found 43 miRNA clusters consisting of about 37.2% (n = 349) of all known miRNAs and located in 80 OMIM '%' loci. The diseases we found significantly associated with the clusters of miRNAs are either associated to a locus, one or more markers and for few of them, several involved genes are known. For six of them we presented a functional study as a result of the integrated analysis of different functional databases (e.g. GO, KEGG pathways, SP-PIR keywords) provided interesting biological support to OMiR findings. As the number of individuals affected by inherited Mendelian disorders, excluding cancers, are usually small and therefore the available samples limited, OMIR can be a useful companion to the scientists for focusing on interesting culprit genes. Furthermore, with the identification of other categories of ncRNAs OMiR algorithm can be re-run for identification of further new possible "protein-less" non-coding culprits.
Our efforts to identify miRNAs important for diseases without known pathogeny are not isolated. Recently two papers have been published with the aim to evaluate human diseases and miRNAs genomic region associations. Lu and colleagues by manually curating the published associations, built a human miRNA associated disease network, suggesting that the applied method can be used in the future to discover novel disease associations [14] . By using a panel of singlenucleotide polymorphisms in miRNAs, Muiños-Gimeno and colleagues identified two miRNA regions showing geographical allelic frequency variation among four HapMAp populations [15] . None of these studies applied and compared the same method to a large scale of diseases already associated with a responsible gene or miRNA and "orphan" disease as we present with OmiR.
Conclusion
We devised and implemented OMiR, an algorithm to compute and study the associations between miRNAs and genetic diseases. We took advantage of the OMIM database to retrieve disease information. Additional association options can be implemented to extend the reach of OMiR, such as the possibility of using markers known by the user that have not yet been published. Moreover, updating OMiR with new OMIM IDs and new miRNAs will increase the robustness of the assay. Our work represents a novel way to extract information on the relationships between miRNAs and diseases with OMIM IDs not associated with a specific disease gene.
Supplementary materials related to this article can be found online at doi:10.1016/j.ygeno.2010.10.004.
